A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick
Not Applicable
- Conditions
- Diabetes
- Registration Number
- NCT02045758
- Lead Sponsor
- Seventh Sense Biosystems
- Brief Summary
This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
-
Healthy Subject Group
- Male and female volunteers 18 years of age or older.
- Voluntary written consent to participate in this study. Diabetic Subject Group
- Male and female volunteers 18 years of age or older.
- Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.
- Voluntary written consent to participate in this study.
Exclusion Criteria
- Subjects who are pregnant or nursing mothers by self-report.
- Subjects with a history of skin disorders or who present with abnormal skin integrity or atypical skin health within the areas to be tested.
- Subjects with a missing index or middle finger on either hand or a missing forearm
- Subjects who have known allergies to titanium.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Non-Inferiority of Analyte Levels Day 1 The study will compare the concentrations of various analytes in blood samples collected by both collection methods in a single 2 hour session.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What microfluidic biosensor technology does TAP20-C use for diabetes analyte detection compared to fingerstick methods?
How does TAP20-C's accuracy in glucose and ketone measurements compare to fingerstick in diabetes patients?
Which biomarkers are measured by TAP20-C and how do they improve diabetes monitoring compared to fingerstick?
What are the safety profiles and adverse event management strategies for TAP20-C versus fingerstick in diabetes blood collection?
Are there other minimally invasive blood collection devices for diabetes monitoring compared to TAP20-C and fingerstick?
Trial Locations
- Locations (1)
Seventh Sense Biosystems
🇺🇸Cambridge, Massachusetts, United States
Seventh Sense Biosystems🇺🇸Cambridge, Massachusetts, United States